blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3400068

EP3400068 - COMPOSITIONS AND METHODS FOR TREATING MALIGNANT, AUTOIMMUNE AND INFLAMMATORY DISEASES [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  26.06.2020
Database last updated on 11.09.2024
FormerRequest for examination was made
Status updated on  12.10.2018
FormerThe international publication has been made
Status updated on  14.07.2017
Formerunknown
Status updated on  21.02.2017
Most recent event   Tooltip13.05.2024New entry: Reply to examination report 
Applicant(s)For all designated states
Yeda Research and Development Co., Ltd.
at the Weizmann Institute of Science
P.O. Box 95
7610002 Rehovot / IL
[2018/46]
Inventor(s)01 / SHACHAR, Idit
156 Aluf David Street
5222208 Ramat-Gan / IL
02 / LEWINSKY, Hadas
c/o Yeda Research and Development CO. LTD.
at the Weizmann Institute of Science
P.O. Box 95
7610002 Rehovot / IL
03 / RADOMIR, Lihi
c/o Yeda Research and Development CO. LTD.
at the Weizmann Institute of Science
P.O. Box 95
7610002 Rehovot / IL
04 / WIENER, Anna
c/o Yeda Research and Development CO. LTD.
at the Weizmann Institute of Science
P.O. Box 95
7610002 Rehovot / IL
 [2018/46]
Representative(s)Dennemeyer & Associates S.A.
Postfach 70 04 25
81304 München / DE
[2018/46]
Application number, filing date17704549.905.01.2017
[2018/46]
WO2017IL50019
Priority number, dateUS201662275378P06.01.2016         Original published format: US 201662275378 P
[2018/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017118985
Date:13.07.2017
Language:EN
[2017/28]
Type: A1 Application with search report 
No.:EP3400068
Date:14.11.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 13.07.2017 takes the place of the publication of the European patent application.
[2018/46]
Search report(s)International search report - published on:EP13.07.2017
ClassificationIPC:A61P35/00, A61P37/00, A61K39/395, A61K31/7088, C12N15/113, C07K16/28
[2018/46]
CPC:
A61K31/713 (EP,US); A61K38/1774 (EP,US); A61P29/00 (EP,US);
A61P35/02 (EP,US); A61P37/06 (EP,US); C07K16/2896 (EP,US);
A61K2039/505 (EP,US); C07K2317/76 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/46]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON BÖSARTIGEN, AUTOIMMUN- UND ENTZÜNDUNGSERKRANKUNGEN[2018/46]
English:COMPOSITIONS AND METHODS FOR TREATING MALIGNANT, AUTOIMMUNE AND INFLAMMATORY DISEASES[2018/46]
French:COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT D'AFFECTIONS MALIGNES, AUTOIMMUNES ET INFLAMMATOIRES[2018/46]
Entry into regional phase26.07.2018National basic fee paid 
26.07.2018Designation fee(s) paid 
26.07.2018Examination fee paid 
Examination procedure26.07.2018Amendment by applicant (claims and/or description)
26.07.2018Examination requested  [2018/46]
26.07.2018Date on which the examining division has become responsible
30.06.2020Despatch of a communication from the examining division (Time limit: M04)
05.11.2020Reply to a communication from the examining division
09.02.2024Despatch of a communication from the examining division (Time limit: M04)
13.05.2024Reply to a communication from the examining division
Fees paidRenewal fee
15.01.2019Renewal fee patent year 03
14.01.2020Renewal fee patent year 04
13.01.2021Renewal fee patent year 05
16.12.2021Renewal fee patent year 06
14.11.2022Renewal fee patent year 07
25.01.2024Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]WO2010035259  (YEDA RES & DEV [IL], et al) [AD] 4-6,11-19,22-26,38-40;
 [AD]WO2015118538  (YEDA RES & DEV [IL]) [AD] 4-6,11-19,22-26,38-40;
 [AD]  - I BINSKY-EHRENREICH ET AL, "CD84 is a survival receptor for CLL cells", ONCOGENE, (20130225), vol. 33, no. 8, doi:10.1038/onc.2013.31, ISSN 0950-9232, pages 1006 - 1016, XP055358089 [AD] 4-6,11-19,22-26,38-40

DOI:   http://dx.doi.org/10.1038/onc.2013.31
 [I]  - SHU DING ET AL, "Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus", ARTHRITIS & RHEUMATISM, (20120901), vol. 64, no. 9, doi:10.1002/art.34505, ISSN 0004-3591, pages 2953 - 2963, XP055137316 [I] 4,5,11-16,38-40 * the whole document *

DOI:   http://dx.doi.org/10.1002/art.34505
 [A]  - OLIVER-VILA ET AL, "The leukocyte receptor CD84 inhibits FcEpsilonRI-mediated signaling through homophilic interaction in transfected RBL-2H3 cells", MOLECULAR IMMUNOLOGY, PERGAMON, GB, (20080219), vol. 45, no. 8, doi:10.1016/J.MOLIMM.2007.12.006, ISSN 0161-5890, pages 2138 - 2149, XP022513093 [A] 4-6,11-19,22-26,38-40

DOI:   http://dx.doi.org/10.1016/j.molimm.2007.12.006
by applicantUS3791932
 US3839153
 US3850752
 US3850578
 US3853987
 US3867517
 US3879262
 US3901654
 US3935074
 US3984533
 US3996345
 US4034074
 US4036945
 US4098876
 US4331647
 US4666828
 US4683202
 US4801531
 US4816567
 US4879219
 EP0375408
 US4946778
 US5011771
 US5192659
 US5272057
 US5281521
 US5545807
 US5545806
 US5569825
 US5625126
 US5633425
 US5661016
 US5721138
 US6326174
 US6348185
 US2002123476
 US2002128218
 US2003017068
 US2003096980
 US2003232410
 US6774279
 US2005027114
 US2005025789
 US2005026157
 US2006014264
 WO2009071334
 WO2010035259
 US8021867
 WO2011146121
 US8119381
 US8124369
 US8129134
 US8133697
 US8143015
 US8143016
 US8148098
 US8163514
 US8304222
 US8586526
 WO2014085593
 US8771945
 WO2015118538
    - BINSKY-EHRENREICH I. ET AL., ONCOGENE, (2014), vol. 33, pages 1006 - 1016
    - BINSKY-EHRENREICH, I. ET AL., ONCOGENE, (2014), vol. 33, no. 8, pages 1006 - 1016
    - YURCHENKO M. ET AL., EXP ONCOL, (2011), vol. 33, no. 1, pages 9 - 18
    - SCHWEIGHOFER C. D. ET AL., PLOS ONE, (2011), vol. 6, no. 12, page E28277
    - GRZYWNOWICZ, M. ET AL., PLOS ONE, (2012), vol. 7, no. 4, page E35178
    - MCCLANAHAN, F. ET AL., BLOOD, (2015), vol. 126, no. 2, pages 203 - 211
    - WOO S.R. ET AL., CANCER RES, (2012), vol. 72, no. 4, pages 917 - 927
    - ITO A. ET AL., BIOMED RES INT, (2015), page 605478
    - PARDOLL, NATURE REVIEWS CANCER, (2012), vol. 12, pages 252 - 264
    - PORTER, R. R, BIOCHEM. J., (1959), vol. 73, pages 119 - 126
    - INBAR ET AL., PROC. NAT'L ACAD. SCI. USA, (1972), vol. 69, pages 2659 - 62
    - WHITLOW; FILPULA, METHODS, (1991), vol. 2, pages 97 - 105
    - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426
    - PACK ET AL., BIO/TECHNOLOGY, (1993), vol. 11, pages 1271 - 77
    - LARRICK; FRY, METHODS, (1991), vol. 2, pages 106 - 10
    - JONES ET AL., NATURE, (1986), vol. 321, pages 522 - 525
    - RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 329
    - PRESTA, CURR. OP. STRUCT. BIOL., (1992), vol. 2, pages 593 - 596
    - RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 327
    - VERHOEYEN ET AL., SCIENCE, (1988), vol. 239, pages 1534 - 1536
    - HOOGENBOOM; WINTER, J. MOL. BIOL., (1991), vol. 227, page 381
    - MARKS ET AL., J. MOL. BIOL., (1991), vol. 222, page 581
    - COLE ET AL., Monoclonal Antibodies and Cancer Therapy, ALAN R. LISS, (1985), page 77
    - BOERNER ET AL., J. IMMUNOL., (1991), vol. 147, no. L, pages 86 - 95
    - MARKS ET AL., BIO/TECHNOLOGY, (1992), vol. 10, pages 779 - 783
    - LONBERG ET AL., NATURE, (1994), vol. 368, pages 856 - 859
    - MORRISON, NATURE, (1994), vol. 368, pages 812 - 13
    - FISHWILD ET AL., NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 845 - 51
    - NEUBERGER, NATURE BIOTECHNOLOGY, (1996), vol. 14, page 826
    - LONBERG; HUSZAR, INTERN. REV. IMMUNOL., (1995), vol. 13, pages 65 - 93
    - STRAT ET AL., NUCLEIC ACIDS RESEARCH, (2006), vol. 34, no. 13, pages 3803 - 3810
    - BHARGAVA A ET AL., BRAIN RES. PROTOC., (2004), vol. 13, pages 115 - 125
    - DIALLO M. ET AL., OLIGONUCLEOTIDES, (2003), vol. 13, pages 381 - 392
    - PADDISON P.J. ET AL., PROC. NATL ACAD. SCI. USA., (2002), vol. 99, pages 1443 - 1448
    - TRAN N. ET AL., FEBS LETT., (2004), vol. 573, pages 127 - 134
    - BILLY ET AL., PNAS, (2001), vol. 98, pages 14428 - 14433
    - DIALLO ET AL., OLIGONUCLEOTIDES, (20031001), vol. 13, no. 5, pages 381 - 392
    - SHINAGWA; ISHII, GENES & DEV., (2003), vol. 17, no. 11, pages 1340 - 1345
    - BRUMMELKAMP, T. R. ET AL., SCIENCE, (2002), vol. 296, page 550
    - CASTANOTTO, D. ET AL., RNA, (2002), vol. 8, page 1454
    - TUSCHLCHEMBIOCHEM, vol. 2, pages 239 - 245
    - BARTEL, CELL, (2004), vol. 116, page 281
    - DOENCH; SHARP, GENESDEV, (2004), vol. 2004, page 504
    - BRENNECKE ET AL., PLOS, (2005), vol. 3, page E85
    - LEWIS, CELL, (2005), vol. 120, page 15
    - KREK ET AL., NAT GENET, (2005), vol. 37, page 495
    - BREAKER, R.R.; JOYCE, G., CHEMISTRY AND BIOLOGY, (1995), vol. 2, page 655
    - SANTORO, S.W.; JOYCE, G.F., PROC. NATL, ACAD. SCI. USA, (1997), vol. 943, page 4262
    - SANTORO, S.W.; JOYCE, G.F., PROC. NATL, ACAD. SCI. USA, page 199
    - KHACHIGIAN, LM, CURROPINMOLTHER, (2002), vol. 4, pages 119 - 21
    - ITOH ET AL., ANN MEETING AM. SOC. GEN. THER., (2002), vol. 409
    - LUFT, J MOL MED, (1998), vol. 76, pages 75 - 6
    - KRONENWETT ET AL., BLOOD, (1998), vol. 91, pages 852 - 62
    - RAJUR ET AL., BIOCONJUGCHEM, (1997), vol. 8, pages 935 - 40
    - LAVIGNE ET AL., BIOCHEMBIOPHYS RES COMMUN, (1997), vol. 237, pages 566 - 71
    - AOKI ET AL., BIOCHEMBIOPHYS RES COMMUN, (1997), vol. 231, pages 540 - 5
    - WALTON ET AL., BIOTECHNOLBIOENG, (1999), vol. 65, pages 1 - 9
    - MATVEEVA ET AL., NATURE BIOTECHNOLOGY, (1998), vol. 16, pages 1374 - 1375
    - HOLMUND ET AL., CURROPINMOLTHER, (1999), vol. 1, pages 372 - 85
    - GERWITZ, CURROPINMOLTHER, (1999), vol. 1, pages 297 - 306
    - UNO ET AL., CANCER RES, (2001), vol. 61, pages 7855 - 60
    - WELCH ET AL., CURROPINBIOTECHNOL., (1998), vol. 9, pages 486 - 96
    - WELCH ET AL., CLINDIAGNVIROL., (1998), vol. 10, pages 163 - 71
    - MAHER III, L. J. ET AL., SCIENCE, (1989), vol. 245, pages 725 - 730
    - MOSER, H. E. ET AL., SCIENCE, (1987), vol. 238, pages 645 - 630
    - BEAL, P. A. ET AL., SCIENCE, (1992), vol. 251, pages 1360 - 1363
    - COONEY, M. ET AL., SCIENCE, (1988), vol. 241, pages 456 - 459
    - SEIDMAN; GLAZER, J CLIN INVEST, (2003), vol. 112, pages 487 - 94
    - VASQUEZ ET AL., NUCL ACIDS RES., (1999), vol. 27, pages 1176 - 81
    - PURI ET AL., J BIOLCHEM, (2001), vol. 276, pages 28991 - 98
    - CARBONE ET AL., NUCL ACID RES., (2003), vol. 31, pages 833 - 43
    - BESCH ET AL., JBIOLCHEM, (2002), vol. 277, pages 32473 - 79
    - VUYISICH; BEAL, NUC. ACIDS RES, (2000), vol. 28, pages 2369 - 74
    - MENKE D, GENESIS, (2013), vol. 51, page 618
    - CAPECCHI, SCIENCE, (1989), vol. 244, pages 1288 - 1292
    - SANTIAGO ET AL., PROC NATL ACADSCI USA, (2008), vol. 105, pages 5809 - 5814
    - CERTO, MT ET AL., NATURE METHODS, (2012), vol. 9, pages 073 - 975
    - REYON ET AL., NATURE BIOTECHNOLOGY, (201205), vol. 30, no. 5, pages 460 - 5
    - MILLER ET AL., NAT BIOTECHNOL., (2011), vol. 29, pages 143 - 148
    - CERMAK ET AL., NUCLEIC ACIDS RESEARCH, (2011), vol. 39, no. 12, page E82
    - ZHANG ET AL., NATURE BIOTECHNOLOGY, (2011), vol. 29, no. 2, pages 149 - 53
    - JINEK ET AL., SCIENCE, (2012), vol. 337, pages 816 - 821
    - IZSVAK; IVICS, MOLECULAR THERAPY, (2004), vol. 9, pages 147 - 156
    - WILSON ET AL., MOLECULAR THERAPY, (2007), vol. 15, pages 139 - 145
    - KAWAKAMI ET AL., PNAS, (2000), vol. 97, no. 21, pages 11403 - 11408
    - MISKEY ET AL., NUCLEIC ACIDS RES., (20031201), vol. 31, no. 23, pages 6873 - 6881
    - CHIORAZZI N; RAI KR; FERRARINI M, "Chronic lymphocytic leukemia", N. ENGL. J. MED., (2005), vol. 352, no. 8, pages 804 - 15
    - KRENN V ET AL., HISTOL HISTOPATHOL, (200007), vol. 15, no. 3, page 791
    - JAN VOSWINKEL ET AL., ARTHRITIS RES, (2001), vol. 3, no. 3, page 189
    - ERIKSON J. ET AL., IMMUNOL RES, (1998), vol. 17, no. 1-2, page 49
    - RENAUDINEAU Y ET AL., CLIN DIAGN LAB IMMUNOL., (199903), vol. 6, no. 2, page 156
    - CHAN OT. ET AL., IMMUNOL REV, (199906), vol. 169, page 107
    - ZIMMET P., DIABETES RES CLIN PRACT, (199610), vol. 34, page S125
    - ORGIAZZI J., ENDOCRINOL METAB CLIN NORTH AM, (200006), vol. 29, no. 2, page 339
    - BRALEY-MULLEN H.; YU S, J IMMUNOL, (20001215), vol. 165, no. 12, page 7262
    - TOYODA N. ET AL., NIPPON RINSHO, (199908), vol. 57, no. 8, page 1810
    - MITSUMA T, NIPPON RINSHO, (199908), vol. 57, no. 8, page 1759
    - GARZA KM. ET AL., J REPROD IMMUNOL, (199802), vol. 37, no. 2, page 87
    - DIEKMAN AB. ET AL., AM J REPROD IMMUNOL., (200003), vol. 43, no. 3, page 134
    - TINCANI A. ET AL., LUPUS, (1998), vol. 7, no. 2, pages 107 - 9
    - CROSS AH. ET AL., J NEUROIMMUNOL, (20010101), vol. 112, no. 1-2, page 1
    - ORON L ET AL., J NEURAL TRANSM, (1997), vol. 49, page 77
    - INFANTE AJ; KRAIG E, INT REV IMMUNOL, (1999), vol. 18, no. 1-2, page 83
    - KORNBERG AJ, J CLIN NEUROSCI., (200005), vol. 7, no. 3, page 191
    - KUSUNOKI S, AM J MED SCI., (200004), vol. 319, no. 4, page 234
    - TAKAMORI M., AM J MED SCI, (200004), vol. 319, no. 4, page 204
    - ANTOINE JC.; HONNORAT J., REV NEUROL (PARIS, (200001), vol. 156, no. 1, page 23
    - NOBILE-ORAZIO E. ET AL., ELECTROENCEPHALOGR CLIN NEUROPHYSIOL SUPPL, (1999), vol. 50, page 419
    - VINCENT A ET AL., ANN N Y ACAD SCI., (19980513), vol. 841, page 482
    - MATSUURA E ET AL., LUPUS, (1998), vol. 7, no. 2, page S135
    - VAARALA O, LUPUS, (1998), vol. 7, no. 2, page S132
    - PRAPROTNIK S. ET AL., WIEN KLIN WOCHENSCHR, (20000825), vol. 112, no. 15-16, page 660
    - LACROIX-DESMAZES S. ET AL., SEMIN THROMB HEMOST., (2000), vol. 26, no. 2, page 157
    - NOEL LH., ANN MED INTERNE (PARIS, (200005), vol. 151, no. 3, page 178
    - FLAMHOLZ R. ET AL., J CLIN APHERESIS, (1999), vol. 14, no. 4, page 171
    - WALLUKAT G. ET AL., AM J CARDIOL., (19990617), vol. 83, no. 12A, page 75H
    - MOCCIA F, ANN ITAL MED INT., (199904), vol. 14, no. 2, page 114
    - EFREMOV DG. ET AL., LEUK LYMPHOMA, (199801), vol. 28, no. 3-4, page 285
    - GARCIA HEROLA A ET AL., GASTROENTEROL HEPATOL., (200001), vol. 23, no. 1, page 16
    - LANDAU YE.; SHOENFELD Y., HAREFUAH, (20000116), vol. 138, no. 2, page 122
    - FEIST E ET AL., INT ARCH ALLERGY IMMUNOL, (200009), vol. 123, no. 1, page 92
    - ZAULI D. ET AL., BIOMED PHARMACOTHER, (199906), vol. 53, no. 5-6, page 234
    - MANNS MP, J HEPATOL, (200008), vol. 33, no. 2, page 326
    - STRASSBURG CP ET AL., EUR J GASTROENTEROL HEPATOL., (199906), vol. LL, no. 6, page 595
    - TISCH R; MCDEVITT HO., PROC NATL ACAD SCI U S A, (19940118), vol. 91, no. 2, page 437
    - DATTA SK., LUPUS, (1998), vol. 7, no. 9, page 591
    - CASTANO L.; EISENBARTH GS, ANN. REV. IMMUNOL., vol. 8, page 647
    - SAKATA S. ET AL., MOL CELL ENDOCRINOL, (199303), vol. 92, no. 1, page 77
    - ALEXANDER RB ET AL., UROLOGY, (199712), vol. 50
    - HARA T. ET AL., BLOOD, (19910301), vol. 77, no. 5, page 1127
    - SODERSTROM M. ET AL., J NEUROL NEUROSURG PSYCHIATRY, (199405), vol. 57, no. 5, page 544
    - OSHIMA M. ET AL., EUR J IMMUNOL, (199012), vol. 20, no. 12, page 2563
    - HIEMSTRA HS ET AL., PROC NATL ACAD SCI USA, (20010327), vol. 98, no. 7, page 3988
    - CUNHA-NETO E. ET AL., J CLIN INVEST, (19961015), vol. 98, no. 8, page 1709
    - SEMPLE JW. ET AL., BLOOD, (19960515), vol. 87, no. 10, page 4245
    - CAPOROSSI AP ET AL., VIRAL IMMUNOL, (1998), vol. 11, no. 1, page 9
    - SALLAH S ET AL., ANN HEMATOL, (199703), vol. 74, no. 3, page 139
    - FRANCO A; 1990 MAR ET AL., CLIN IMMUNOL IMMUNOPATHOL, vol. 54, no. 3, page 382
    - JONES DE, CLIN SCI (COLCH, (199611), vol. 91, no. 5, page 551
    - KELLY CJ, J AM SOC NEPHROL, (199008), vol. L, no. 2, page 140
    - YOO TJ. ET AL., CELL IMMUNOL, (199408), vol. 157, no. 1, page 249
    - GLODDEK B ET AL., ANN N Y ACAD SCI, (19971229), vol. 830, page 266
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING CO.
    - MCGARY ET AL., "Animal models for viral infection and cell exhaustion", CURR OPIN HIV AIDS, (2014), vol. 9, no. 5, pages 492 - 499
    - BICHI R ET AL., PROC NATL ACAD SCI USA, (2002), vol. 99, no. 10, pages 6955 - 6960
    - SHIMONI A; MARCUS H; CANAAN A ET AL., "A model for human B-chronic lymphocytic leukemia in human/mouse radiation chimera: evidence for tumor-mediated suppression of antibody production in low-stage disease", BLOOD, (1997), vol. 89, pages 2210 - 2218
    - "chapter1", FINGL ET AL., The Pharmacological Basis of Therapeutics, (1975), page 1
    - AUSUBEL, R. M., Current Protocols in Molecular Biology, (1994), vol. I-III
    - WATSON ET AL., Recombinant DNA, SCIENTIFIC AMERICAN BOOKS
    - BIRREN ET AL., Genome Analysis: A Laboratory Manual Series, COLD SPRING HARBOR LABORATORY PRESS, (1998), vol. 1-4
    - CELLIS, J. E., Cell Biology: A Laboratory Handbook, (1994), vol. I-III
    - COLIGAN J. E., Current Protocols in Immunology, (1994), vol. I-III
    - Methods in Enzymology, ACADEMIC PRESS, vol. 1-317
    - KURTOVA, A. V. ET AL., BLOOD, (2009), vol. 114, no. 20, pages 4441 - 4450
    - BINSKY, I ET AL., PROC NATL ACAD SCI U S A, (2007), vol. 104, no. 33, pages 13408 - 13413
    - BINSKY, I. ET AL., J IMMUNOL, (2010), vol. 184, no. 9, pages 4761 - 4769
    - BICHI R. ET AL., PROC NATL ACAD SCI USA, (2002), vol. 99, no. 10, pages 6955 - 6960
    - CANNONS J. L. ET AL., IMMUNITY, (2010), vol. 32, pages 253 - 65
    - CANNONS J. L. ET AL., ANNU REV IMMUNOL, (2011), vol. 29, pages 665 - 705
    - HOFBAUER J. P. ET AL., LEUKEMIA, (2011), vol. 25, no. 9, pages 1452 - 1458
    - NORDE, W. J ET AL., CANCER RES, (2011), vol. 71, no. 15, pages 5111 - 5122
    - BAITSCH, L ET AL., PLOS ONE, (2012), vol. 7, no. 2, page E30852
    - DURAISWAMY, J. ET AL., CANCER RES, (2013), vol. 73, no. 12, pages 3591 - 3603
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.